Poseida Therapeutics, Inc. (PSTX)
9.50
0.00 (0.00%)
USD |
NASDAQ |
Jan 08, 16:00
Poseida Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| January 08, 2025 | 10.61 |
| January 07, 2025 | 10.61 |
| January 06, 2025 | 10.68 |
| January 03, 2025 | 10.63 |
| January 02, 2025 | 10.50 |
| December 31, 2024 | 10.72 |
| December 30, 2024 | 10.59 |
| December 27, 2024 | 10.52 |
| December 26, 2024 | 10.62 |
| December 24, 2024 | 10.60 |
| December 23, 2024 | 10.59 |
| December 20, 2024 | 10.56 |
| December 19, 2024 | 10.51 |
| December 18, 2024 | 10.54 |
| December 17, 2024 | 10.61 |
| December 16, 2024 | 10.62 |
| December 13, 2024 | 10.62 |
| December 12, 2024 | 10.61 |
| December 11, 2024 | 10.62 |
| December 10, 2024 | 10.56 |
| December 09, 2024 | 10.54 |
| December 06, 2024 | 10.45 |
| December 05, 2024 | 10.42 |
| December 04, 2024 | 10.51 |
| December 03, 2024 | 10.42 |
| Date | Value |
|---|---|
| December 02, 2024 | 10.41 |
| November 29, 2024 | 10.40 |
| November 27, 2024 | 10.42 |
| November 26, 2024 | 10.48 |
| November 25, 2024 | 3.194 |
| November 22, 2024 | 3.049 |
| November 21, 2024 | 3.027 |
| November 20, 2024 | 3.038 |
| November 19, 2024 | 3.094 |
| November 18, 2024 | 2.982 |
| November 15, 2024 | 3.083 |
| November 14, 2024 | 3.586 |
| November 13, 2024 | 3.664 |
| November 12, 2024 | 4.122 |
| November 11, 2024 | 4.144 |
| November 08, 2024 | 3.440 |
| November 07, 2024 | 3.273 |
| November 06, 2024 | 3.105 |
| November 05, 2024 | 2.971 |
| November 04, 2024 | 2.826 |
| November 01, 2024 | 2.759 |
| October 31, 2024 | 2.647 |
| October 30, 2024 | 2.658 |
| October 29, 2024 | 2.737 |
| October 28, 2024 | 2.770 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Abeona Therapeutics, Inc. | 2.547 |
| America Great Health | -- |
| Acumen Pharmaceuticals, Inc. | 3.738 |
| Aardvark Therapeutics, Inc. | 1.457 |
Price to Book Value Related Metrics
| Price | 9.50 |